SUMMARY Evidence of necrotising enterocolitis was found in 14 of 111 neonatal cardiac catheterisations. A close temporal relationship between investigation and the onset of necrotising enterocolitis was apparent in many cases but no predisposing factors could be identified.
Necrotising enterocolitis (NEC) is known to be an important cause of morbidity and mortality in neonatal intensive care units.1 2 It is seen mainly in preterm infants but has been reported in term ones including some with congenital heart disease.' 3 Recently Cooke et al. 4 A comparison of possible predisposing factors in those who developed NEC and those who did not showed no statistically significant differences between the two groups ( Table 2 ).
Discussion
Since this investigation was prompted by two clusters of cases it is probable that the prevalence of NEC reported is higher than the true prevalence of this complication among neonates with congenital heart disease. Nevertheless, it is clear that 
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The pathogenesis of NEC is imperfectly understood but injury to the bowel mucosa and the subsequent entry of gas-forming organisms into the bowel wall are presumed to be important factors. Hypoxia, hypotension, and local vascular changes are potential causes of mucosal injury and a history of perinatal asphyxia and the use of umbilical vessel catheters have been shown to be significantly associated with the development of NEC in preterm infants.6 An analysis of several known and other possible predisposing factors to NEC in our cases showed no significant differences between the two groups and the cause of NEC among these patients therefore remains unknown.
The angiographic contrast medium formerly used during cardiac catheterisation in this unit, sodium iothalamate (Conray 420), has an osmolality of 2100 mmol/l. Cooke et al. 4 suggested that the hyperosmolar effect of the injection of contrast medium might result in damage to the colonic mucosa leading to NEC and that the use of contrast media with a lower osmolality might avoid this complication. Regrettably this has not been the case and the frequency with which NEC developed in patients investigated using meglumine/sodium ioxaglate (Hexabrix, osmolality 600 mmol/l) and metrizamide (Ampique, osmolality 480 mmol/l) was similar to that in patients who received sodium iothalamate. It is possible that toxic substances from plastic components of the apparatus may leak out and be responsible for vascular changes in the portal system as has previously been suggested in cases of NEC after exchange transfusion.7 However, the apparatus used was the same for all infants and the duration of cardiac catheterisation is short when compared with an indwelling umbilical vessel catheter. It therefore seems unlikely that this offers a complete explanation for the frequency of NEC in these patients.
In the absence of any recognisable predisposing factors we cannot make any recommendations which might result in a reduction in the prevalence of this problem. Although reports of NEC after cardiac catheterisation are few in number4 we feel that it should be recognised as an important association in this age group. In many cases, the illness is fairly mild and similar to that described by Leonidas and 
